logo Immuno-Oncology 360°
logo Immuno-Oncology 360°

The Immuno-Oncology 360° Summit reports on the rapid advancements of clinical, scientific, and business developments of IO in one setting for a wider range of cancers at an accelerated rate.

The 5th annual Immuno-Oncology (IO) 360° is the premier meeting across all stakeholders in IO, addressing the rapid advancements of clinical, scientific and business developments of IO in one setting to help develop therapeutics for a wider range of cancers at an accelerated rate.
The 3 day summit features 10 plenary sessions with over 80 speakers and includes over 10 hours of networking. There will be over 450 attendees representing pharma, biotech, academia, research organizations, business development and the investment community focused on IO. Designed by Dr Axel Hoos, GSK, Dr James Gulley, NCI, and Dr Andrew Baum, Citi, the IO360° program addresses aspects from all facets of IO including:

- Discovery/Preclinical Science
- Translational Science
- Clinical Data Development
- Clinical Operations
- Cell Therapy
- Imaging Aspects
- Emerging Technologies
- Business Aspects
- Emerging Technologies
- Financial And Commercial Implications
- Trends in the Field

The IO360° Summit reports on the most current data and rapid advancements to help IO stakeholders:

- Be at the forefront of the most relevant research and developments from key leadership who are at the pulse of cancer immunotherapy
- Foster collaboration amongst those working in all aspects of cancer immunotherapy together
- Partner to expand technology platforms to develop therapeutics at an accelerated rate
- Receive the latest pre-clinical, translational, and clinical data from academic and industry
- Identify and gain a greater understanding of what assets are available for potential combinations
- Create and prioritize strategies targeted toward specific tumor types
- Hear from IO clinical trial leaders as they cover trial design, clinical operations, the latest outcomes and lessons learned
- Get key investor and analyst insights on the IO landscape, challenges, investment decision-making And next steps
- Learn about biomarker advancements in vaccines, imaging, neoantigen approaches and more
- Obtain coverage on a wide range of emerging technologies

URLs:
Brochure: https://go.evvnt.com/288750-3?pid=5528
Booking: https://go.evvnt.com/288750-4?pid=5528

Speakers: James Gulley, MD, PhD, Axel Hoos, MD, PhD, Andrew Baum, MD, Tara Arvedson, PhD, Andrea van Elsas, PhD, Ronald Herbst, PhD, Priti Hegde, PhD, Jonathan Zalevsky, PhD, David Leung, MD, PhD, Tahamtan Ahmadi, MD, PhD, Aung Naing, MD, FACP, Kelie Luby, Maher Albitar, MD, Khalil Barrage, Jeff Bockman, PhD, Cedrik Britten, MD, John D Carroll, Daniel Chen, MD, PhD, Adriana Comprelli, Karen Dimick, David Epstein, MBA, Simone Fishburn, PhD, Asthika Goonewardene, MBA, Patrice Hugo, PhD, Michael Kalos, PhD, Jacqueline Karmel, Sadik Kassim, PhD, Lanny Kirsch, MD, Ron Korn, MD, PhD, Theresa LaVallee, PhD, Ian McCaffery, PhD, Matthew Mulvey, PhD, Martin Oft, MD, Mark Paris, PhD, Andrea Perrone, MD, Ian Pyrah, PhD, Eric Rubin, MD, Marco Ruella, MD, Lawrence Schwartz, MD and more

Time: 8:00 am to 4:00 pm

Practical Info

Prices:
Industry / Pharma and Biotech starting rate: USD 1995.0,
Standard Industry starting rate: USD 1995.0,
Academia, Non-Profit And Government starting rate: USD 997.5

logo user
logo user

Share your own experience!

Immuno-Oncology 360°

Reviews are public and modifiable.

Satisfaction Indicators from ratings shared by community members

Ratings & Reviews for this conference by community members

Previous Events

  Total Domestic Foreign
Visitors
Exhibitors
Represented firms
Exhibitors' Countries
Sq.M.
Put your ads on Bestrade!

Organizers

, United States

Discover the best events in my industry

Discover now